Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity

Yiyang Gong; Yun Ke; Zichuan Yu; Jingying Pan; Xuanrui Zhou; Yike Jiang; Minqin Zhou; Hong Zeng; Xitong Geng; Guowen Hu

doi:doi:10.18632/aging.204962

← Back

Research Paper Volume 15, Issue 16 pp 8155—8184

Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity

Figure 3. Relationship between RP2 and prognosis of glioma patients. Glioma patients with lower expression level of RP2 had favorable (A) OS (HR = 2.37, p < 0.001), (B) DSS (HR = 2.54, p < 0.001), (C) PFS (HR = 1.98, p < 0.001). (D) Nomograms and (E) calibration curves.